• Please Remember: Members are only permitted to share their own experiences. Members are not qualified to give medical advice. Additionally, everyone manages their health differently. Please be respectful of other people's opinions about their own diabetes management.
  • We seem to be having technical difficulties with new user accounts. If you are trying to register please check your Spam or Junk folder for your confirmation email. If you still haven't received a confirmation email, please reach out to our support inbox: support.forum@diabetes.org.uk

World-first type 1 diabetes drug trial aims to reprogram immune system

Amity Island

Well-Known Member
Relationship to Diabetes
Type 1
The immune system starts to recognise insulin-producing cells in the pancreas as something it needs to attack and destroy in people with type 1 diabetes — one of dozens of auto-immune diseases in which the body starts to attack itself.

Professor Thomas, who is based at UQ's Frazer Institute, said the experimental drug — dubbed ASITI-201 — was designed to retrain the immune system so it no longer attacks the insulin-producing pancreatic cells, known as beta cells.

The drug, given as an injection under the skin, combines fragments of a protein found in the beta cells of people with type 1 diabetes and vitamin D to calm the immune response.

 
Interesting about the vitamin D link as my vitamin D was low at diagnosis.
This sounds like a sort of desensitising therapy.
 
Sounds interesting for those recently diagnosed. I sometimes wonder if new beta cells would grow in those who’d had Type 1 longer if the immune system was no longer killing them off. That would be nice if they did.
 
Back
Top